Literature DB >> 23907780

Advanced colorectal neoplasia risk stratification by penalized logistic regression.

Yunzhi Lin1, Menggang Yu2, Sijian Wang3, Richard Chappell3, Thomas F Imperiale4.   

Abstract

Colorectal cancer is the second leading cause of death from cancer in the United States. To facilitate the efficiency of colorectal cancer screening, there is a need to stratify risk for colorectal cancer among the 90% of US residents who are considered "average risk." In this article, we investigate such risk stratification rules for advanced colorectal neoplasia (colorectal cancer and advanced, precancerous polyps). We use a recently completed large cohort study of subjects who underwent a first screening colonoscopy. Logistic regression models have been used in the literature to estimate the risk of advanced colorectal neoplasia based on quantifiable risk factors. However, logistic regression may be prone to overfitting and instability in variable selection. Since most of the risk factors in our study have several categories, it was tempting to collapse these categories into fewer risk groups. We propose a penalized logistic regression method that automatically and simultaneously selects variables, groups categories, and estimates their coefficients by penalizing the [Formula: see text]-norm of both the coefficients and their differences. Hence, it encourages sparsity in the categories, i.e. grouping of the categories, and sparsity in the variables, i.e. variable selection. We apply the penalized logistic regression method to our data. The important variables are selected, with close categories simultaneously grouped, by penalized regression models with and without the interactions terms. The models are validated with 10-fold cross-validation. The receiver operating characteristic curves of the penalized regression models dominate the receiver operating characteristic curve of naive logistic regressions, indicating a superior discriminative performance.
© The Author(s) 2013.

Entities:  

Keywords:  colorectal cancer; interaction; lasso; penalized logistic regression; risk stratification

Mesh:

Year:  2013        PMID: 23907780      PMCID: PMC4250434          DOI: 10.1177/0962280213497432

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  15 in total

Review 1.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

2.  Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.

Authors:  Olaide Y Raji; Olorunsola F Agbaje; Stephen W Duffy; Adrian Cassidy; John K Field
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

5.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Authors:  Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

6.  Lasso tree for cancer staging with survival data.

Authors:  Yunzhi Lin; Sijian Wang; Richard J Chappell
Journal:  Biostatistics       Date:  2012-12-05       Impact factor: 5.899

Review 7.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.

Authors:  Yikyung Park; Andrew Nathan Freedman; Mitchell H Gail; David Pee; Albert Hollenbeck; Arthur Schatzkin; Ruth M Pfeiffer
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

10.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

View more
  2 in total

Review 1.  Risk Prediction Models for Colorectal Cancer: A Systematic Review.

Authors:  Juliet A Usher-Smith; Fiona M Walter; Jon D Emery; Aung K Win; Simon J Griffin
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-13

2.  Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.

Authors:  Jia Wang; Ping Zhu; Zhao Cui; Zhen Qu; Yi-Miao Zhang; Fang Wang; Xin Wang; Jin-Wei Wang; Sai-Nan Zhu; Gang Liu; Fu-de Zhou; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.